Document Detail


Triterpenoids.
MedLine Citation:
PMID:  22592567     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Covering: 2010. Previous review: Nat. Prod. Rep., 2011, 28, 1087-1117This review covers the isolation and structure determination of triterpenoids, including squalene derivatives, protostanes, lanostanes, holostanes, cycloartanes, dammaranes, euphanes, tirucallanes, tetranortriterpenoids, quassinoids, lupanes, oleananes, friedelanes, ursanes, hopanes, serratanes and saponins; 305 references are cited.
Authors:
Robert A Hill; Joseph D Connolly
Related Documents :
22432597 - T-cell lymphoblastic lymphoma/leukemia presenting as a pituitary mass lesion: a case re...
21292347 - Holistic approach to treatment of intractable central neuropathic itch.
3336947 - Transthoracic needle aspiration biopsy. review of 233 cases.
22666717 - Clear cell adenocarcinoma of a female urethra: a case report and review of the literature.
18657927 - Fever, abdominal pain, and leukopenia in a 13-year-old: a case-based review of meningoc...
10894957 - Revival of the use of botulinum toxin: application in dermatology.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-17
Journal Detail:
Title:  Natural product reports     Volume:  -     ISSN:  1460-4752     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8502408     Medline TA:  Nat Prod Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
School of Chemistry, Glasgow University, Glasgow, UK G12 8QQ.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary infections imitating lung cancer: clinical presentation and therapeutical approach.
Next Document:  Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts.